New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
10:05 EDTITMN, FN, VSAT, SEAS, LVMUY, INFY, ADDYY, URS, QLYS, JONE, FCX, WYNN, TBPH, MSGOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Adidas (ADDYY) downgraded to Neutral from Buy at Goldman... Fabrinet (FN) downgraded at B. Riley... Freeport McMoRan (FCX) downgraded at Stifel... Infosys (INFY) downgraded to Hold from Buy at Jefferies... InterMune (ITMN) downgraded to Neutral from Buy at Goldman... Jones Energy (JONE) downgraded to Neutral from Overweight at JPMorgan... LVMH Moet Hennessy (LVMUY) downgraded to Neutral from Buy at Goldman... Madison Square Garden (MSG) downgraded to Hold from Buy at Topeka... Qualys (QLYS) downgraded to Sector Perform from Outperform at RBC Capital... SeaWorld (SEAS) downgraded to Market Perform from Outperform at Wells Fargo... Theravance Biopharma (TBPH) downgraded to Underperform from Neutral at RW Baird... URS Corporation (URS) downgraded to Neutral from Buy at Sterne Agee... ViaSat (VSAT) downgraded to Perform from Outperform at Oppenheimer... Wynn Resorts (WYNN) downgraded to Hold from Buy at Gabelli.
News For ADDYY;FN;FCX;INFY;ITMN;JONE;LVMUY;MSG;QLYS;SEAS;TBPH;URS;VSAT;WYNN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 19, 2015
05:23 EDTVSATViaSat selected by Gulfstream as sole source Ku-Band equipment supplier
Subscribe for More Information
May 18, 2015
15:23 EDTWYNNWynn Resorts management to meet with JPMorgan
Meeting to be held in New York on May 21 hosted by JPMorgan.
08:08 EDTTBPHTheravance Biopharma presents positive Phase 2 study data on velusetrag
Theravance Biopharma announced the presentation of positive data from a Phase 2 study of velusetrag, an investigational drug for the treatment of patients with gastroparesis and other gastrointestinal motility disorders, in a "Poster of Distinction" at Digestive Disease Week, or DDW, 2015 in Washington, D.C. Presented data showed that all three doses of velusetrag reduced gastric emptying time compared to placebo in patients with either diabetic or idiopathic gastroparesis. Findings from the study in 34 subjects with diabetic or idiopathic gastroparesis demonstrated reductions in GE t1/2, in minutes and percentage of baseline GE t1/2, of 35, 34, and 52 minutes at doses of 5, 15, and 30 mg, respectively, as compared to 13 minutes for placebo. The proportion of subjects demonstrating at least a 20% change from baseline in GE t1/2 was statistically significant for those subjects receiving velusetrag 30 mg compared to placebo. The proportion of subjects demonstrating at least a 20% change from baseline in GE t1/2 in the 5 mg and 15 mg velusetrag treatment groups was 26% and 20%, respectively. Importantly, similar reductions in GE t1/2 were observed in both diabetic and idiopathic gastroparetic subjects treated with velusetrag. All doses of velusetrag were generally well tolerated with diarrhea and headache as the most common adverse events. No on-treatment serious adverse events were observed.
May 17, 2015
15:07 EDTINFYInfosys likely to spend cash on acquisitions rather than returns, Barron's says
Infosys is likely to spend its capital on additional acquisitions rather than shareholder returns, Barron's contends in its 'International Trader - Asia' column. Barron's notes that the company has targeted an 18% annualized rate of revenue growth and looks to deepen its presence in social, mobile, "big data," and cloud through buyouts. Reference Link
May 15, 2015
10:01 EDTSEASOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:01 EDTWYNNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:43 EDTWYNNWynn Resorts downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
May 14, 2015
16:10 EDTSEASSeaWorld initiated with a Neutral at Wedbush
Subscribe for More Information
16:00 EDTFCXOptions Update; May 14, 2015
Subscribe for More Information
13:28 EDTFCXIncreasing equity options volume
Increasing equity options volume: FCX UPS KSS CHK CSCO AVP YOKU CALM KORS
10:14 EDTFCXFreeport McMoRan call activity attributed to takeover speculation
Freeport McMoRan May 23 and 23.5 calls are active on total call volume of 14K contracts (1K puts) on takeover speculation. May call option implied volatility is at 34, June is at 40, October is at 38; compared to its 26-week average of 40. Active option volume suggests traders taking positions for wide price movement.
10:05 EDTFCXRumor: Freeport McMoRan strength attributed to takeover speculation
The 3% move higher in shares of Freeport McMoRan is being attributed to speculation of a takeover.
09:17 EDTJONEJones Energy 5M share Spot Secondary priced at $10.00
The deal priced below the $10.25-$10.75 range. JPMorgan acted as sole book running manager for the offering.
06:38 EDTADDYYadidas sees India among top five markets by 2020, Times of India says
Subscribe for More Information
May 13, 2015
16:07 EDTJONEJones Energy files to sell 5M shares of Class A common stock for holders
Subscribe for More Information
07:21 EDTQLYSCredit Suisse to hold a conference
4th Annual Disruptive Technology Conference is being held in San Francisco on May 13-14 with webcasted company presentations to begin on May 13 at 10:35 am; not all company presentations may be webcasted. Webcast Link
07:16 EDTVSATMoffett Nathanson to hold a summit
Subscribe for More Information
07:10 EDTVSATB. Riley to hold a conference
Subscribe for More Information
May 12, 2015
08:28 EDTADDYYadidas CEO says no approach made on large stake or takeover, Reuters says
Despite a Manager Magazin report last September that activist investors were considering taking a stake in adidas and pushing for change, CEO Herbert Hainer told journalists that "nobody has approached us because they want to buy the company or buy a large number of shares," according to Reuters. Adidas' CEO defended the hiring of Perella Weinberg Partners as advisers to help fend off any potential hostile bids, stating that the company "just [wants] to make sure that anybody who invests has the right intentions," the report added. Reference Link
May 11, 2015
17:39 EDTINFYInfosys refocuses on top clients, Economic Times says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use